# Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.

> **NCT00484718** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** celecoxib
- **DRUG:** Oxycodone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00484718
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01-17
- **Primary completion:** 2009-06-10
- **Final completion:** 2009-06-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484718, "Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00484718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*